Antipsychotic Drugs Market Research Report -Forecast till 2027

Antipsychotic Drugs Market Research Report: Information by Generation (First Generation, Second Generation), Types of Antipsychotics (Atypical Antipsychotics, Miscellaneous Antipsychotics Agents), Therapeutic Applications(Schizophrenia, Anxiety, Bipolar Disorder) and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2067-HCR | February 2021 | Region: Global | 90 pages

Antipsychotic Drugs Market Overview


During the ongoing forecast period of 2020-2027, the antipsychotic drugs market size is expected to grow at a compound annual growth rate (CAGR) of 5.7%. Based on the trends and the rising entry of the new players to cater to the needs of an elaborated target audience, the market operations are likely to be valued at USD 33.59 billion by the end of the forecast period in 2027.


The antipsychotic drugs market players are of the small. Medium, and large sizes. The main aim for them to opt for innovative means is to strive for a strong business footprint that will work in their favor by expanding the production facilities and cater to the demand of the presence of innovative drugs.


COVID 19 Analysis


Since the world has come in contact with the emergence of the fatal coronavirus pandemic, the economies are at a standstill as the lockdown has been imposed and there are many functional restrictions. Most of the countries are in full lockdown and this is leading to reduced availability of skilled labor and talent that will make the right and judicious use of the resources that are already available in lesser quantities. Industrial and human activities are the worst affected due to the pandemic and are looking for ways that will help them cover the losses incurred during the pandemic and emerge as global competitors by the end of the forecast period in 2027.


However, the proactive steps that are underway with the help of the industry leaders and antipsychotic drugs market experts are likely to play a major role in reviving the industry demand and maintain a proper flow of the supply chain mechanism. Also, the rising investment from the public sector and the government sector is giving rise to the research and development initiatives that will drive the market towards growth. The market players are also opting for creative means to develop medical drugs that will help the audience spread at an international scale.


Antipsychotic Drugs Market Dynamics


Drivers


Based on the study conducted and the result formulated by the American Psychiatric Association (APA), during the historic year of 2018, every 1 out of the 24 patients was recognized to have suffered from serious mental disorders that are inclusive of serious psychotic disorders. The steep increase in the number of people who are suffering from serious mental disorders is increasing the existing burden on the healthcare system, the healthcare services, and the healthcare service providers. As a result, there is a rise in the focus from the end of the government on the creation of a good and reliable degree of awareness regarding the diseases and related symptoms. The result of this is that the prominent players of the market are investing and employing their best workforce in the development of highly efficient and safe drugs that act as assets while treating patients who have psychotic diseases and are spread in various parts across the globe.


Restraints


However, one of the major factors that are likely to act as a restraint for the market players on the path of its global growth during the forecast period that ends in 2027 is the lack of awareness and recognition. Most people are in denial about the psychotic disorders that are increasing at a massive rate across various parts of the globe. Also, the target audience who have a reliable idea about the disorder are not aware of the remedies and treatment that will help the patients that are suffering from such disorders. Some of the people also face the issue of affordability which is likely to be worked upon by the market players during the forecast period that ends in 2027.


Technology Analysis


The target audience that recognizes and accepts these mental disorders are on the search for market operations and services that are safe and reliable. The global market players are on the path of launching new and innovative market products like injectable drugs that will help in eliminating the need to monitor the degree to which the patient opts for the drug intake. All the market trends and technological advancements pose a positive attribute that will help the market to grow during the forecast period that ends in 2027.


Antipsychotic Drugs Market Segmentation


The antipsychotic drugs market has been divided all across the globe based on the therapeutic applications, generation, end-users, and industry.


Based on the Therapeutic Applications


The antipsychotic drugs market has been divided all across the globe based on the therapeutic applications into dementia, depression, bipolar disorder, anxiety, schizophrenia, and many others.


Based on the Generation


The antipsychotic drugs market has been divided all across the globe based on the generation into the third generation, second generation, and first-generation.


Based on the End-User Industry


The market has been divided all across the globe based on the end-user industry into research institutes, hospitals, and various other industries.


Based on the Region


The market has been divided in the global market based on the region into North American region, Asia-Pacific region, European region, Latin American region, and the Middle East and African region.


Antipsychotic Drugs Market Regional Analysis


The antipsychotic drugs market has been divided all across the globe based on the region into North American region, Asia-Pacific region, European region, Latin American region, and the Middle East and African region. The largest market share in the global market is held by the North American region owing to increasing health awareness that drives the market demand in this region. Moreover, the presence of countries like the US, Canada, and Mexico is another factor that drives the market demand in this region.


The second-largest antipsychotic drugs market share in the global market is held by the European region owing to increasing depression, stress, and mental illness due to increased working hours drives the market demand to this region. Moreover, the presence of a well-established technologically advanced healthcare system is another driving factor.


Being the fastest-growing region, the third-largest market share in the global market is held by the Asia-Pacific region as a large chunk of the population is suffering from various chronic and mental diseases that drive the market demand to this region. Increasing concern about mental and physical health is another factor that drives the market demand.


The Latin American region and the Middle East and African region hold the least market share due to the presence of low infrastructure in both these regions. The reduction in the per capita disposable income of people is another contributing factor that restricts the market scope.


Antipsychotic Drugs Market Competitive Landscape


The most prominent major key players in the antipsychotic drugs market all across the globe are mentioned below:



  • Johnson and Johnson (US)

  • GlaxoSmithKline Plc. (UK)

  • Pfizer Inc. (US)

  • AstraZeneca (UK)

  • Bristol-Myers Squibb (US)

  • Eli Lily & Co. (US)


These major key players use various strategies to sustain their market position in the antipsychotic drugs market in the global market by going for mergers, and acquisitions, by collaborating, setting up a new joint venture, establishing a partnership, developing a new product line, innovation in the existing product, developing a new production process, and many others to expand their customer base in the untapped market of the antipsychotic drugs all across the globe.


Recent Developments



  • Johnson and Johnson (US) is spending a huge sum of money on research and development to get an upper edge over its competitors. This will help the company in increasing its sales revenue.

  • All the major market key players are highly investing in mergers and acquisitions, joint ventures, and new product launches.

  • In July 2018, a specialty pharmaceuticals business based in UK called Indivior PLC has received approval from FDA for a long-acting injectable (LAI), Perseris containing risperidone. It will help the company in treating schizophrenia, especially in adults.

  • In March 2020, Ziprasidone Mesylate for injection has been launched by Dr. Reddy’s Laboratories for 20 mg (base) per single-dose vials. It will enhance the company’s portfolio in the United States.


Report Overview


This global antipsychotic drugs market research report consists of the following elements mentioned below:



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Technical Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This market research report contains factors that drive the growth of the antipsychotic drugs market in the global market along with the factors that restrict its growth in the global market. The impact of COVID 19 on the market all across the globe is mentioned. The future growth rate in the market during the forecasted period is estimated and mentioned.


Intended Audience


Academic centers, ambulatory surgery centers, hospitals, approval and diagnostic centers, suppliers and distributors, pharmaceutical manufacturing companies.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: 33.59 billion
  CAGR   2020-2027: 5.7%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Generation, Types of Antipsychotics, Therapeutic Applications
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Eli Lilly & Co. (US), Bristol-Myers Squibb (US), AstraZeneca (UK), Pfizer Inc. (US), GlaxoSmithKline Plc. (UK), and Johnson & Johnson (US)
  Key Market Opportunities   The Growing number of mental hospitals
  Key Market Drivers

  • Increasing Awareness and focus on mental illness.
  • Increasing depression due to stressed lifestyle.


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Global Antipsychotic Drugs Market is projected to grow at a 5.7% CAGR between 2020-2027.

    The Americas is predicted to dominate antipsychotic drugs market

    It is extensively used to treat bipolar disorder, anxiety, and schizophrenia

    Increasing number of mental hospitals and rising prevalence of depression are boosting market growth

    Table of Contents

    1. REPORT PROLOGUE

    2. MARKET INTRODUCTION

    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    3. RESEARCH METHODOLOGY

    3.1. Overview

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation

    4. MARKET DYNAMICS

    4.1. Overview

    4.2. Drivers

    4.3. Restraints

    4.4. Opportunities

    5. MARKET FACTOR ANALYSIS

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis


    6. GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS

    6.1. Overview

    6.2. Schizophrenia

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3. Anxiety

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4. Bipolar Disorder

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5. Depression

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6. Dementia

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7. GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION

    7.1. Overview

    7.2. First Generation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3. Second Generation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4. Third Generation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8. GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY END USER

    8.1. Overview

    8.2. Hospitals & Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3. Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9. GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY REGION

    9.1. Overview

    9.2. Americas

    9.2.1. North America

    9.2.1.1. US

    9.2.1.2. Canada

    9.2.2. Latin America

    9.3. Europe

    9.3.1. Western Europe

    9.3.1.1. Germany

    9.3.1.2. France

    9.3.1.3. Italy

    9.3.1.4. Spain

    9.3.1.5. UK

    9.3.1.6. Rest of Western Europe

    9.3.2. Eastern Europe

    9.4. Asia-Pacific

    9.4.1. Japan

    9.4.2. China

    9.4.3. India

    9.4.4. Australia

    9.4.5. South Korea

    9.4.6. Rest of Asia-Pacific

    9.5. Middle East & Africa

    9.5.1. Middle East

    9.5.2. Africa

    10. COMPANY LANDSCAPE

    10.1. Overview

    10.2. Competitive Analysis

    10.3. Market Share Analysis

    10.4. Major Growth Strategy in the global Antipsychotic Drugs Market

    10.5. Competitive Benchmarking

    10.6. Leading Players in terms of Number of Developments in the Global Antipsychotic Drugs Market

    10.7. Key developments and Growth Strategies

    10.7.1. New Product Launch/Service Deployment

    10.7.2. Merger & acquisitions

    10.7.3. Joint Ventures

    10.8. Major Players Financial Matrix & Market Ratio

    10.8.1. Sales & Operating Income 2020

    10.8.2. Major Players R&D Expenditure 2020

    10.9. Major Players Capital Market Ratio

    11. COMPANY PROFILES

    11.1. Eli Lilly & Co.

    11.1.1. Company Overview

    11.1.2. Product Overview

    11.1.3. Financial Overview

    11.1.4. Key Developments

    11.1.5. SWOT Analysis

    11.1.6. Key Strategies

    11.2. Bristol-Myers Squibb

    11.2.1. Company Overview

    11.2.2. Product Overview

    11.2.3. Financial Overview

    11.2.4. Key Developments

    11.2.5. SWOT Analysis

    11.2.6. Key Strategies

    11.3. AstraZeneca

    11.3.1. Company Overview

    11.3.2. Product Overview

    11.3.3. Financial Overview

    11.3.4. Key Developments

    11.3.5. SWOT Analysis

    11.3.6. Key Strategies

    11.4. GlaxoSmithKline PLC

    11.4.1. Company Overview

    11.4.2. Product Overview

    11.4.3. Financial Overview

    11.4.4. Key Developments

    11.4.5. SWOT Analysis

    11.4.6. Key Strategies

    11.5. Pfizer Inc.

    11.5.1. Company Overview

    11.5.2. Product Overview

    11.5.3. Financial Overview

    11.5.4. Key Developments

    11.5.5. SWOT Analysis

    11.5.6. Key Strategies

    11.6. Johnson & Johnson

    11.6.1. Company Overview

    11.6.2. Product Overview

    11.6.3. Financial Overview

    11.6.4. Key Developments

    11.6.5. SWOT Analysis

    11.6.6. Key Strategies

    11.7. Others

    12. APPENDIX

    12.1. References

    12.2. Related Reports

    LIST OF TABLES

    TABLE 1 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SYNOPSIS, 2020-2027

    TABLE 2 GLOBAL ANTIPSYCHOTIC DRUGS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

    TABLE 3 GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 4 GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 5 GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 6 GLOBAL ANTIPSYCHOTIC DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 7 NORTH AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 8 NORTH AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 9 NORTH AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 10 US: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 11 US: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 12 US: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 13 CANADA: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 14 CANADA: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 15 CANADA: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 16 LATIN AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 17 LATIN AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 18 LATIN AMERICA: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 19 EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 20 EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 21 EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 22 WESTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 23 WESTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 24 WESTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 25 EASTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 26 EASTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 27 EASTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 28 ASIA-PACIFIC: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 29 ASIA-PACIFIC: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 30 ASIA-PACIFIC: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 31 MIDDLE EAST & AFRICA: ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC APPLICATIONS, 2020-2027 (USD MILLION)

    TABLE 32 MIDDLE EAST & AFRICA: ANTIPSYCHOTIC DRUGS MARKET, BY GENERATION, 2020-2027 (USD MILLION)

    TABLE 33 MIDDLE EAST & AFRICA: ANTIPSYCHOTIC DRUGS MARKET, BY END USER, 2020-2027 (USD MILLION)


    LIST OF FIGURES

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIPSYCHOTIC DRUGS MARKET

    FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIPSYCHOTIC DRUGS MARKET

    FIGURE 4 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY THERAPEUTIC APPLICATIONS, 2020 (%)

    FIGURE 5 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY GENERATION, 2020 (%)

    FIGURE 6 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY END USER, 2020 (%)

    FIGURE 7 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 7 AMERICAS: ANTIPSYCHOTIC DRUGS MARKET SHARE BY REGION, 2020 (%)

    FIGURE 8 NORTH AMERICA: ANTIPSYCHOTIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 9 EUROPE: ANTIPSYCHOTIC DRUGS MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 10 WESTERN EUROPE: ANTIPSYCHOTIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 11 ASIA-PACIFIC: ANTIPSYCHOTIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 12 MIDDLE EAST & AFRICA: ANTIPSYCHOTIC DRUGS MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 13 GLOBAL ANTIPSYCHOTIC DRUGS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

    FIGURE 14 ELI LILLY & CO..: KEY FINANCIALS

    FIGURE 15 ELI LILLY & CO.: SEGMENTAL REVENUE

    FIGURE 16 ELI LILLY & CO.: REGIONAL REVENUE

    FIGURE 17 BRISTOL-MYERS SQUIBB: KEY FINANCIALS

    FIGURE 18 BRISTOL-MYERS SQUIBB: SEGMENTAL REVENUE

    FIGURE 19 BRISTOL-MYERS SQUIBB: REGIONAL REVENUE

    FIGURE 20 ASTRAZENECA: KEY FINANCIALS

    FIGURE 21 ASTRAZENECA: SEGMENTAL REVENUE

    FIGURE 22 ASTRAZENECA: REGIONAL REVENUE

    FIGURE 23 GLAXOSMITHKLINE PLC: KEY FINANCIALS

    FIGURE 24 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

    FIGURE 25 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

    FIGURE 26 PFIZER INC.: KEY FINANCIALS

    FIGURE 27 PFIZER INC.: SEGMENTAL REVENUE

    FIGURE 28 PFIZER INC.: REGIONAL REVENUE

    FIGURE 29 JOHNSON & JOHNSON: KEY FINANCIALS

    FIGURE 30 JOHNSON & JOHNSON: SEGMENTAL REVENUE

    FIGURE 31 JOHNSON & JOHNSON: REGIONAL REVENUE